Equipped with world-class research facilities, the institute enables researchers to conduct both qualitative and quantitative research. This facilitates gaining insights into various aspects of patient care, healthcare management, digital medicine, disease pathophysiology, diagnostics, and therapy development.
A particular emphasis is placed on an outstanding biomedical research program that focuses on areas such as molecular medicine, regenerative medicine, molecular diagnostics, biomarker development, drug discovery, and biotherapeutics. This program is well-supported by an exceptional infrastructure.
In addition to the robust biomedical research program, the institute boasts a comprehensive clinical research initiative, which forms the cornerstone of its medical research. Supported by extensive patient data documented by the Medical Records Department, the clinical research program ensures patient safety and rights through competent Institutional Ethics Committees (IEC), Institutional Biosafety Committees (IBS), Institutional Review Boards (IRB), and Research and Innovation Councils.
The clinical trials conducted at the institute aim to translate scientific discoveries into tangible improvements in patient care. From testing novel therapies to assessing the efficacy of existing treatments in diverse patient populations, the clinical research arm plays a pivotal role in advancing evidence-based medicine. Researchers actively engage in clinical trials addressing prevalent health issues in the region, including infectious diseases, cardiovascular disorders, and cancer.
Since its inception, the research programs at the institution have continuously evolved, establishing standout biomedical and clinical research initiatives that have positively impacted the global medical research landscape.